Negligence, malpractice and recklessness committed by otorhinolaryngologists in the state of São Paulo-Brazil. [PDF]
Marquezini Chammes RM, Fujita RR.
europepmc +1 more source
Practising Applied Ethics with philosophical integrity: the case of Business Ethics [PDF]
Deon Rossouw
openalex +1 more source
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi +14 more
wiley +1 more source
Correction: The cost of community outreach HIV interventions: a case study in Thailand. [PDF]
Soe KM, Hauck K, Jiamton S, Kongsin S.
europepmc +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
From the Editors: De Ethica. A Journal of Philosophical, Theological and Applied Ethics (English)
Marcus Agnafors
openalex +2 more sources
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski +10 more
wiley +1 more source
Educating Students About Digital Health Research Ethics: Curricula Review and Expert Interview Study. [PDF]
Zhu Y +4 more
europepmc +1 more source
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht +3 more
wiley +1 more source
Editorial Note: Repertoire of Intensive Care Unit Pneumonia Microbiota. [PDF]
PLOS One Editors.
europepmc +1 more source

